Serologicals to launch $110 million loan via J.P. Morgan

By Paul A. Harris

St. Louis, Sept. 17 - Serologicals Corp. will launch a $110 million credit facility Thursday, according to a market source.

J.P. Morgan is the lead bank on the deal.

The facility will be comprised of an $80 million term loan and a $30 million revolving credit facility.

Price talk on the term loan is Libor plus 225 basis points.

Proceeds will be used to help fund the acquisition of Upstate Group, a Charlottesville, Va.-based supplier of cell-signaling research reagents.

Serologicals is a Norcross, Ga.-based biological research group.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.